This inventor holds 28 USPTO granted patents and 3 published patent applications and 15 EPO patents, primarily in ROCK Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Sloan-Kettering Institute for Cancer Research, Bristol-Myers Squibb Pharma Company. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wilmingtonq, DE (US) (2006)
- Wilmington, DE (US) (2003 - 2007)
- Yardley, PA (US) (2006 - 2023)
Company Filing History:
24 out of 3,745 
3 out of 519 
1 out of 234 
Years Active: 2003-2023
Areas of Expertise:
Title: The Innovative Journey of Inventor Peter W Glunz
Introduction: Peter W Glunz, a prolific inventor based in Yardley, PA (US), has made significant contributions to the field of pharmaceuticals with a total of 28 patents under his belt. His dedication to innovation has paved the way for groundbreaking advancements in medicine.
Latest Patents: Among his latest patented inventions are 5-membered and bicyclic heterocyclic amides as inhibitors of ROCK. These compounds have shown great promise as selective ROCK inhibitors, with implications for treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and inflammatory disorders. The pharmaceutical compositions derived from his inventions have the potential to revolutionize the treatment of a wide range of medical conditions.
Career Highlights: Peter W Glunz has been associated with prominent companies such as Bristol-Myers Squibb Company and the Sloan-Kettering Institute for Cancer Research. His professional journey has been marked by a relentless pursuit of excellence and a commitment to pushing the boundaries of scientific discovery.
Collaborations: Throughout his career, Peter W Glunz has collaborated with esteemed professionals in the field, including coworkers like Vladimir Ladziata and Mimi Lifen Quan. These collaborative efforts have led to the development of innovative solutions that have the power to transform the landscape of modern medicine.
Conclusion: Peter W Glunz stands as a beacon of inspiration for inventors worldwide, showcasing the transformative impact of unwavering dedication to innovation. His pioneering work continues to shape the future of medicine, offering hope and possibilities for patients and researchers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile